New Analysis: Preparing Your Provider Strategy for Medicare Price Negotiations

As your team prepares for Medicare drug price negotiations, understanding the downstream impact on provider economics will be crucial for maintaining strong customer relationships. Our latest analysis examines how Maximum Fair Prices (MFP) could reshape provider margin dynamics—and what that means for your engagement strategy.?

In our new analysis, we answered the key questions:?

• What are the likely manufacturer discounting approaches for drugs with an MFP price??

• How will different discount approaches impact provider buy-and-bill margins post-MFP???

• When and how should you signal changes to maintain provider confidence??

This analysis draws from HMP Market Access Intelligence's comprehensive research across IDNs, community practices, and payers to provide actionable insights for your team's 2026 planning.?

Download our whitepaper today.?